Vigabatrin - Epilepsy
You are here : Home > Formulary Search > Vigabatrin - Epilepsy
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Sachets (powder)
- Tablets
Formulary Status :
Restrictions / Comments :
Important
Specialist initiation before transfer of prescribing to primary care
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Vigabatrin
Indication :
Epilepsy
Group Name :
Keywords :
Brand Names Include :
Sabril, Kigabeq
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Vigabatrin is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Epilepsy.
- Brivaracetam
- Cannabis (medicinal)
- Carbamazepine
- Cenobamate
- Clobazam
- Clonazepam
- Eslicarbazepine acetate
- Ethosuximide
- Gabapentin
- Lacosamide
- Lamotrigine
- Levetiracetam
- Oxcarbazepine
- Perampanel
- Phenobarbital
- Phenytoin
- Pregabalin
- Primidone
- Rufinamide
- Sodium valproate (NON childbearing potential)
- Sodium valproate (with childbearing potential)
- Stiripentol
- Sulthiame
- Tiagabine
- Topiramate
- Zonisamide
Committee Recommendations (1)
Vigabatrin soluble tablets are currently not on the APC workplan. The APC will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Please contact your local CCG Medicines Management team OR formulary pharmacist at your acute trust, if you wish to make a submission.